vs

Side-by-side financial comparison of Chaince Digital Holdings Inc. (CD) and PULSE BIOSCIENCES, INC. (PLSE). Click either name above to swap in a different company.

Chaince Digital Holdings Inc. is the larger business by last-quarter revenue ($466.6K vs $264.0K, roughly 1.8× PULSE BIOSCIENCES, INC.). Chaince Digital Holdings Inc. runs the higher net margin — -640.5% vs -6603.4%, a 5962.9% gap on every dollar of revenue.

Colossal Biosciences Inc. is an American biotechnology and genetic engineering company working to de-extinct several extinct animals, including the woolly mammoth, the Tasmanian tiger, the northern white rhinoceros, the dire wolf, the dodo, and the moa. In 2023, it stated that it wants to have woolly mammoth hybrid calves by 2028, and wants to reintroduce them to the Arctic tundra habitat. Likewise, it launched the Tasmanian Thylacine Advisory Committee, a thylacine research project to releas...

CD vs PLSE — Head-to-Head

Bigger by revenue
CD
CD
1.8× larger
CD
$466.6K
$264.0K
PLSE
Higher net margin
CD
CD
5962.9% more per $
CD
-640.5%
-6603.4%
PLSE

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
CD
CD
PLSE
PLSE
Revenue
$466.6K
$264.0K
Net Profit
$-3.0M
$-17.4M
Gross Margin
Operating Margin
-665.1%
-6914.0%
Net Margin
-640.5%
-6603.4%
Revenue YoY
Net Profit YoY
10.1%
EPS (diluted)
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CD
CD
PLSE
PLSE
Q4 25
$264.0K
Q3 25
$86.0K
Q2 25
$466.6K
$0
Q1 25
$0
Q4 24
$0
Q3 24
$0
Q2 24
$0
Q1 24
$0
Net Profit
CD
CD
PLSE
PLSE
Q4 25
$-17.4M
Q3 25
$-19.4M
Q2 25
$-3.0M
$-19.2M
Q1 25
$-16.8M
Q4 24
$-19.4M
Q3 24
$-12.7M
Q2 24
$-11.4M
Q1 24
$-10.1M
Gross Margin
CD
CD
PLSE
PLSE
Q4 25
Q3 25
-224.4%
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
CD
CD
PLSE
PLSE
Q4 25
-6914.0%
Q3 25
-23682.6%
Q2 25
-665.1%
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Net Margin
CD
CD
PLSE
PLSE
Q4 25
-6603.4%
Q3 25
-22540.7%
Q2 25
-640.5%
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
EPS (diluted)
CD
CD
PLSE
PLSE
Q4 25
Q3 25
Q2 25
$-0.05
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CD
CD
PLSE
PLSE
Cash + ST InvestmentsLiquidity on hand
$27.2M
$80.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$29.4M
$80.7M
Total Assets
$36.6M
$94.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CD
CD
PLSE
PLSE
Q4 25
$80.7M
Q3 25
$95.2M
Q2 25
$27.2M
$106.3M
Q1 25
$119.3M
Q4 24
$118.0M
Q3 24
$79.0M
Q2 24
$26.2M
Q1 24
$34.9M
Stockholders' Equity
CD
CD
PLSE
PLSE
Q4 25
$80.7M
Q3 25
$92.7M
Q2 25
$29.4M
$104.5M
Q1 25
$118.5M
Q4 24
$114.9M
Q3 24
$79.1M
Q2 24
$27.0M
Q1 24
$36.3M
Total Assets
CD
CD
PLSE
PLSE
Q4 25
$94.5M
Q3 25
$108.8M
Q2 25
$36.6M
$120.3M
Q1 25
$133.4M
Q4 24
$132.5M
Q3 24
$93.0M
Q2 24
$40.4M
Q1 24
$49.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CD
CD
PLSE
PLSE
Operating Cash FlowLast quarter
$-1.3M
$-14.8M
Free Cash FlowOCF − Capex
$-14.9M
FCF MarginFCF / Revenue
-5628.8%
Capex IntensityCapex / Revenue
39.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-54.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CD
CD
PLSE
PLSE
Q4 25
$-14.8M
Q3 25
$-13.0M
Q2 25
$-1.3M
$-12.8M
Q1 25
$-13.5M
Q4 24
$-9.1M
Q3 24
$-9.0M
Q2 24
$-8.4M
Q1 24
$-9.8M
Free Cash Flow
CD
CD
PLSE
PLSE
Q4 25
$-14.9M
Q3 25
$-13.1M
Q2 25
$-12.9M
Q1 25
$-13.6M
Q4 24
$-9.2M
Q3 24
$-9.1M
Q2 24
$-8.4M
Q1 24
$-9.8M
FCF Margin
CD
CD
PLSE
PLSE
Q4 25
-5628.8%
Q3 25
-15233.7%
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Capex Intensity
CD
CD
PLSE
PLSE
Q4 25
39.8%
Q3 25
72.1%
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons